Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Singular Genomics Systems, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Ropp Sam (Chief Commercial Officer) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.5355, valued at
$53.6k
|
|
| 08/15/2023 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Sold 353,657 shares
@ $0.5955, valued at
$210.6k
Sold 77,991 shares
@ $0.5696, valued at
$44.4k
Sold 200,000 shares
@ $0.5348, valued at
$107k
|
|
| 08/08/2023 |
4
| Eisenberg Marcia (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 148,000 options to buy
@ $0.747, valued at
$110.6k
|
|
| 05/26/2023 |
4
| Kamdar Kim P. (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 74,000 options to buy
@ $1.06, valued at
$78.4k
|
|
| 05/26/2023 |
4
| Mardis Elaine R (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 74,000 options to buy
@ $1.06, valued at
$78.4k
|
|
| 05/26/2023 |
4
| Pellini Michael J (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.06, valued at
$106k
|
|
| 05/26/2023 |
4
| Ryan Jason (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 74,000 options to buy
@ $1.06, valued at
$78.4k
|
|
| 05/26/2023 |
4
| BARKER DAVID L (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 74,000 options to buy
@ $1.06, valued at
$78.4k
|
|
| 05/18/2023 |
4
| Glezer Eli N. (Chief Scientific Officer) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Bought 170,000 shares
@ $0.8172, valued at
$138.9k
|
|
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Glezer Eli N. (Chief Scientific Officer) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Bought 50,000 shares
@ $2, valued at
$100k
|
|
| 07/11/2022 |
4
| BARKER DAVID L (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Exercised 60,000 options to buy
@ $0.63, valued at
$37.8k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2022 |
4
| Spaventa Andrew (CEO) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Disposed of 173,144 shares
@ $0
Acquired 9,766 shares
@ $0 |
|
| 03/08/2022 |
4
| Spaventa Andrew (CEO) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $7.5, valued at
$7.5M
|
|
| 03/08/2022 |
4
| Meeter Dalen (Senior Vice President, Finance) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 187,500 options to buy
@ $7.5, valued at
$1.4M
|
|
| 03/08/2022 |
4
| Glezer Eli N. (Chief Scientific Officer) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 500,000 options to buy
@ $7.5, valued at
$3.8M
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
4
| Mardis Elaine R (Director) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 40,000 options to buy
@ $9.07, valued at
$362.8k
|
|
| 12/06/2021 |
4
| Spaventa Andrew (CEO) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Disposed of 715,884 shares
@ $0 |
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Spaventa Andrew (CEO) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Converted 715,884 shares
@ $0
Converted 173,144 shares
@ $17.6, valued at
$3M
Converted 362,266 options to buy
@ $0
Converted 201,155 preferred shares
@ $0
Converted 152,463 preferred shares
@ $0
Converted 173,144 convertible notes
@ $0 |
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Meeter Dalen (Senior Vice President, Finance) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Granted 50,000 options to buy
@ $22, valued at
$1.1M
|
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|